It is possible that the higher frequency of STAT3 mutations in our study than in Barilà et al. (Barilà et al., 2023) (80% vs 38.1%) can be explained by the presence of RA in the majority of patients in our cohort. This evidence concerns the gene STAT3 and rheumatoid arthritis.